Brief: Oryzon H1 Net Loss Widens To 1.0 Mln Euros YoY
July 31 (Reuters) - Oryzon Genomics SA ORY.MC :
* H1 NET LOSS 1.0 MILLION EUROS VERSUS LOSS 568,224 EUROS
YEAR AGO
Source text for Eikon: ID:nCNM8RBsNf
Further company coverage: ORY.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on ORYZON Genomics SA
See all newsBrief: Oryzon Gets New Patent Grants For Vafidemstat In Four Countries
Brief: Oryzon Gets EMA Approval To Start Phase II Study Of Vafidemstat For PMS Treatment
Spanish stocks - Factors to watch on Aug 31
Brief: Oryzon Gets U.S. Patent Allowance For Iadademstat And Gilteritinib Drug Combo Application
Spanish stocks - Factors to watch on July 28